Physician

Joon Sung Park, MD

According to 2025 Medicare claims, Joon Park, MD (NPI: 1699894709) practices nephrology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is PARAGON HEALTH, PC (NPI: 1083678767; TIN: 383309299) and primary practice location at 49009-5928. Park is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626) and Caravan Health ACO 43 LLC (ACO ID: A4974), participating under the MSSP model.

Park's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 281 traditional Medicare patients, billed 896 HCPCS/CPT codes, and received $120,193 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,115 prescription claims across 307 beneficiaries totaling $570,323 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 56 claims. Open Payments data shows 3 records totaling $70. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $228,600 to $120,193. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $227,254 to $570,323. For DME billing, this smaller-volume category changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	565	1,901	$228,600
2016	554	1,888	$229,415
2017	558	1,935	$232,587
2018	531	1,702	$220,489
2019	528	1,712	$224,880
2020	413	1,287	$182,692
2021	379	1,178	$174,778
2022	349	1,056	$137,736
2023	276	781	$102,561
2024	281	896	$120,193

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	217	1,212	$227,254
2016	256	1,465	$330,001
2017	255	1,694	$322,726
2018	260	1,527	$165,445
2019	271	1,656	$195,799
2020	249	1,492	$210,762
2021	275	1,639	$278,474
2022	313	1,858	$309,266
2023	327	2,009	$495,803
2024	307	2,115	$570,323

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	106	$6,218
2016	N/R	133	$6,093
2017	N/R	133	$4,649
2018	N/R	108	$3,749
2019	N/R	66	$1,610
2020	N/R	114	$2,918
2021	N/R	92	$2,172
2022	N/R	56	$1,882
2023	N/R	67	$1,513
2024	N/R	56	$1,003

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	49	287	$265
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	31	31	$114
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	48	56	$96
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	62	131	$56
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	122	222	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	537	20,714	$381,647
Jardiance	Empagliflozin	78	3,617	$67,162
Lokelma	Sodium Zirconium Cyclosilicate	27	1,046	$22,411
Veltassa	Patiromer Calcium Sorbitex	19	630	$18,322
Dapagliflozin	Dapagliflozin Propanediol	18	826	$13,607

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	14	$304
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	14	$292
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$245
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$70	Mallinckrodt Hospital Products Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joon Sung Park, MD?

Tedicare shows public-source Medicare data for Joon Sung Park, MD (NPI 1699894709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joon Sung Park, MD have ACO affiliation data?

Joon Sung Park, MD is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626) and Caravan Health ACO 43 LLC (MSSP, ACO ID A4974).

What billing organization is linked to Joon Sung Park, MD?

Joon Sung Park, MD is linked to PARAGON HEALTH, PC (billing NPI 1083678767) in the available physician profile data.

Does Joon Sung Park, MD have Open Payments data?

Joon Sung Park, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.